These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 25173187)

  • 1. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach.
    Shamshirsaz AA; Fox KA; Salmanian B; Diaz-Arrastia CR; Lee W; Baker BW; Ballas J; Chen Q; Van Veen TR; Javadian P; Sangi-Haghpeykar H; Zacharias N; Welty S; Cassady CI; Moaddab A; Popek EJ; Hui SK; Teruya J; Bandi V; Coburn M; Cunningham T; Martin SR; Belfort MA
    Am J Obstet Gynecol; 2015 Feb; 212(2):218.e1-9. PubMed ID: 25173187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta.
    Marcellin L; Delorme P; Bonnet MP; Grange G; Kayem G; Tsatsaris V; Goffinet F
    Am J Obstet Gynecol; 2018 Aug; 219(2):193.e1-193.e9. PubMed ID: 29733839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team.
    Erfani H; Fox KA; Clark SL; Rac M; Rocky Hui SK; Rezaei A; Aalipour S; Shamshirsaz AA; Nassr AA; Salmanian B; Stewart KA; Kravitz ES; Eppes C; Coburn M; Espinoza J; Teruya J; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2019 Oct; 221(4):337.e1-337.e5. PubMed ID: 31173748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol.
    Melber DJ; Berman ZT; Jacobs MB; Picel AC; Conturie CL; Zhang-Rutledge K; Binder PS; Eskander RN; Roberts AC; McHale MT; Ramos GA; Ballas J; Kelly TF
    Am J Obstet Gynecol; 2021 Oct; 225(4):442.e1-442.e10. PubMed ID: 34245679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta.
    Cali G; Forlani F; Giambanco L; Amico ML; Vallone M; Puccio G; Alio L
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():36-41. PubMed ID: 24965977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.
    Matsuzaki S; Mandelbaum RS; Sangara RN; McCarthy LE; Vestal NL; Klar M; Matsushima K; Amaya R; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol; 2021 Nov; 225(5):534.e1-534.e38. PubMed ID: 33894149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum.
    Zuckerwise LC; Craig AM; Newton JM; Zhao S; Bennett KA; Crispens MA
    Am J Obstet Gynecol; 2020 Feb; 222(2):179.e1-179.e9. PubMed ID: 31469990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alternate surgical approach to reduce hemorrhage and complications during cesarean hysterectomy for adherent placenta.
    Saha PK; Bagga R; Kalra JK; Arora A; Singla R; Suri V; Jain K; Kumar P; Gupta N; Jain A; Singh T; Mavuduru RS
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():215-220. PubMed ID: 30007249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time.
    Shamshirsaz AA; Fox KA; Erfani H; Clark SL; Salmanian B; Baker BW; Coburn M; Shamshirsaz AA; Bateni ZH; Espinoza J; Nassr AA; Popek EJ; Hui SK; Teruya J; Tung CS; Jones JA; Rac M; Dildy GA; Belfort MA
    Am J Obstet Gynecol; 2017 Jun; 216(6):612.e1-612.e5. PubMed ID: 28213059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management of placenta accreta: a 10-year experience.
    Grace Tan SE; Jobling TW; Wallace EM; McNeilage LJ; Manolitsas T; Hodges RJ
    Acta Obstet Gynecol Scand; 2013 Apr; 92(4):445-50. PubMed ID: 23311505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Maternal morbidity and mortality associated with conservative management for placenta morbidly adherent (accreta) diagnosed during pregnancy. Report of 15 cases].
    Daney de Marcillac F; Lecointre L; Guillaume A; Sananes N; Fritz G; Viville B; Boudier E; Nisand I; Gaudineau A; Langer B; Akladios CY
    J Gynecol Obstet Biol Reprod (Paris); 2016 Oct; 45(8):849-858. PubMed ID: 27118678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placenta accreta: Elective versus emergent delivery as a major predictor of blood loss.
    Seoud MA; Nasr R; Berjawi GA; Zaatari GS; Seoud TM; Shatila AS; Mirza FG
    J Neonatal Perinatal Med; 2017; 10(1):9-15. PubMed ID: 28304318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency delivery in pregnancies at high probability of placenta accreta spectrum on prenatal imaging: a systematic review and meta-analysis.
    Lucidi A; Janiaux E; Hussein AM; Nieto-Calvache A; Khalil A; D'Amico A; Rizzo G; D'Antonio F
    Am J Obstet Gynecol MFM; 2024 Oct; 6(10):101432. PubMed ID: 39069207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and neonatal outcomes following a proactive peripartum multidisciplinary management protocol for placenta creta spectrum as compared to the urgent delivery.
    Stanleigh J; Michaeli J; Armon S; Khatib F; Zuckerman B; Shaya M; Ioscovitch A; Shenfeld O; Greenblat D; Farkash R; Tevet A; Samueloff A; Grisaru Granovsky S
    Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():139-144. PubMed ID: 31039488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and maternal outcome in morbidly adherent placenta.
    Sultana N; Mohyuddin S; Jabbar T
    J Ayub Med Coll Abbottabad; 2011; 23(2):93-6. PubMed ID: 24800353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Standardized Approach for Transfusion Medicine Support in Patients With Morbidly Adherent Placenta.
    Panigrahi AK; Yeaton-Massey A; Bakhtary S; Andrews J; Lyell DJ; Butwick AJ; Goodnough LT
    Anesth Analg; 2017 Aug; 125(2):603-608. PubMed ID: 28640786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified cesarean hysterectomy technique for management of cases of placenta increta and percreta at a tertiary referral hospital in Egypt.
    Hussein AM; Kamel A; Raslan A; Dakhly DMR; Abdelhafeez A; Nabil M; Momtaz M
    Arch Gynecol Obstet; 2019 Mar; 299(3):695-702. PubMed ID: 30607590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidly adherent placenta.
    Abuhamad A
    Semin Perinatol; 2013 Oct; 37(5):359-64. PubMed ID: 24176160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of management of placenta accreta spectrum by transverse uterine fundal incision in a single tertiary care centre: A retrospective study.
    Roy KK; Zangmo R; Das A; Suresh G; Rai R; Girish B; Kumari A; P V; Bharti J; Singhal S; Meena J
    Natl Med J India; 2024; 37(1):9-12. PubMed ID: 39096226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic endovascular internal iliac balloon placement during cesarean hysterectomy for placenta accreta spectrum.
    Overton E; Booker WA; Mourad M; Moroz L; Nhan Chang CL; Breslin N; Syeda S; Laifer-Narin S; Cimic A; Chung DE; Weiner DM; Smiley R; Sheikh M; Mobley DG; Wright JD; Gockley A; Melamed A; St Clair C; Hou J; D'Alton M; Khoury Collado F
    Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100657. PubMed ID: 35597402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.